Hematologists Accepting Anthem Blue Cross Blue Shield

Jaroslaw Maciejewski, MD

Professor of Medicine

Hematology

Leo Gordon, MD

Professor, Feinberg School of Medicine

Hematology

Jane Winter, MD

Professor, Feinberg School of Medicine, Division of Hematology Oncology

Hematology

George Fisher, MD

Associate Professor, Medicine, Stanford University School of Medicine

Hematology

David Henry, MD

Vice Chair, Department of Medicine; Clinical Professor of Medicine (Hematology-Oncology)

Hematology

Paolo Caimi, M.D.

Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director for Cell Therapy, Cleveland Clinic Taussig Cancer Center

Hematology

Michael Morse, M.D.

Professor of Medicine, Duke University School of Medicine

Hematology

Steven Rosenfeld, MD

Professor of Neurology, Neuro-Oncology

Hematology

Judy Garber, M.D.

Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.&nb

Hematology

Anjali Advani, M.D.

Hematology

Tauseef Ahmed, M.D.

Chief of Oncology, Westchester Medical Center; Professor of Medicine, New York Medical College

Hematology

David Dingli, M.D.

Professor of Medicine, Division of Hematology, Mayo Clinic

Hematology

Jeffrey Crawford, MD

George Barth Geller Distinguished Professor for Research in Cancer, Professor of Medicine

Hematology

Gary Schiller, MD

Medical Oncologist specializing in Leukemia and Hematologic Malignancy

Hematology

Matt Kalaycio, MD

Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Hematology

Bartosz Chmielowski, MD, PHD

Health Sciences Clinical Professor of Medicine, Division of Hematology-Oncology

Hematology

Angela Dispenzieri, M.D.

Professor of Medicine and Laboratory Medicine and Pathology / Consultant

Hematology

Keith McCrae, MD

Director, Benign Hematology and Classical Hematology

Hematology

Lawrence Einhorn, MD

Distinguished Professor, Livestrong Foundation Professor of Oncology, Professor of Medicine, Indiana University School of Medicine

Hematology

Glenn Hanna, M.D.

Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff

Hematology